PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000 | -19.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $16,200 | -23.9% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,300 | -42.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $37,000 | -99.5% | 10,000 | -50.0% | 0.00% | – |
| Q3 2022 | $7,007,000 | +87487.5% | 20,000 | +100.0% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 10,000 | -4.8% | 0.00% | – |
| Q1 2022 | $10,000 | -88.1% | 10,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $84,000 | -4.5% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | +31.3% | 10,500 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $67,000 | +1.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | +57.1% | 10,000 | 0.0% | 0.00% | – |
| Q4 2020 | $42,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |